10,199 Shares in Bruker Co. (NASDAQ:BRKR) Bought by Alberta Investment Management Corp

Alberta Investment Management Corp bought a new position in shares of Bruker Co. (NASDAQ:BRKR) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,199 shares of the medical research company’s stock, valued at approximately $598,000.

Several other institutional investors have also recently made changes to their positions in BRKR. Retirement Systems of Alabama increased its holdings in Bruker by 11.7% in the third quarter. Retirement Systems of Alabama now owns 134,254 shares of the medical research company’s stock valued at $9,272,000 after buying an additional 14,069 shares in the last quarter. Cerity Partners LLC increased its holdings in Bruker by 446.8% in the third quarter. Cerity Partners LLC now owns 27,998 shares of the medical research company’s stock valued at $1,934,000 after buying an additional 22,878 shares in the last quarter. Merit Financial Group LLC purchased a new position in Bruker in the fourth quarter valued at $300,000. Brown Brothers Harriman & Co. increased its holdings in Bruker by 39.9% in the third quarter. Brown Brothers Harriman & Co. now owns 602,144 shares of the medical research company’s stock valued at $41,584,000 after buying an additional 171,806 shares in the last quarter. Finally, FMR LLC increased its holdings in Bruker by 21.4% in the third quarter. FMR LLC now owns 14,306,122 shares of the medical research company’s stock valued at $987,981,000 after buying an additional 2,521,904 shares in the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Bruker Stock Performance

BRKR opened at $50.82 on Friday. The firm has a market capitalization of $7.70 billion, a PE ratio of 66.87, a PEG ratio of 2.16 and a beta of 1.16. Bruker Co. has a twelve month low of $48.07 and a twelve month high of $94.86. The firm’s 50-day moving average price is $56.73 and its 200 day moving average price is $60.03. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. As a group, sell-side analysts expect that Bruker Co. will post 2.69 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on BRKR. UBS Group began coverage on shares of Bruker in a research report on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 target price on the stock. TD Cowen dropped their target price on shares of Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a research report on Wednesday, November 6th. Citigroup dropped their target price on shares of Bruker from $80.00 to $75.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. The Goldman Sachs Group upgraded shares of Bruker from a “sell” rating to a “neutral” rating and set a $60.00 target price on the stock in a research report on Thursday, December 5th. Finally, Barclays dropped their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $70.50.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.